- Home
- ADAG vs NATR Comparison
ADAG vs NATR Comparison
Compare ADAG & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADAG | NATR |
|---|---|---|
| Founded | 2011 | 1972 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.2M | 220.6M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ADAG | NATR |
|---|---|---|
| Price | $2.47 | $12.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $9.91 | ★ $30.50 |
| AVG Volume (30 Days) | ★ 368.0K | 87.5K |
| Earning Date | 08-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.00 |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $480,144,000.00 |
| Revenue This Year | N/A | $3.24 |
| Revenue Next Year | $129.59 | $4.74 |
| P/E Ratio | ★ N/A | $26.03 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $1.30 | $12.00 |
| 52 Week High | $4.85 | $28.14 |
Technical Indicators
Market Signals| Indicator | ADAG | NATR |
|---|---|---|
| Relative Strength Index (RSI) | 30.39 | 29.90 |
| Support Level | $1.50 | $12.31 |
| Resistance Level | $3.50 | $21.17 |
| Average True Range (ATR) | 0.25 | 0.35 |
| MACD | -0.06 | 0.11 |
| Stochastic Oscillator | 13.43 | 47.50 |
Price Performance
Historical ComparisonAbout ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.